Tag Archives: global leadership
Dear Research Advocate,
This is the time of year when many of us attempt to translate our successes, defeats, observations and unfulfilled goals into New Year’s resolutions. I have some thoughts about resolutions in the context of advocacy for research to improve health. I welcome your feedback as Research!America continues to fight for funding and a policy environment that propels medical and health progress forward.
1) We will not only push for pro-innovation policy making, we will push for policy making itself. In other words: leadership, bipartisanship and compromise. The recent bipartisan, bicameral budget action in Congress is a small step in the right direction, but it is just the beginning of a long journey. Without a clear vision of the future and a cooperative spirit across parties, across disciplines and across sectors, support for research will continue to stagnate.
2) We will not only fight to end sequestration and dispense with draconian budget caps, we will fight for tax and entitlement reform. Without the latter, some manner of assault on discretionary budget priorities is inevitable.
3) We will fight to ensure that the voices of Americans are heard when it comes to making research and innovation a higher priority. In launching our election-year voter education campaign, we will reach out to the hearts and minds of Americans nationwide, seeking media as well as policy maker and would-be policy maker attention to a topic that is taken too much for granted.
4) We will not lower our expectations. The budget compromise is a good thing, but the most essential thing is making research for health a much higher national priority. Other nations are doing this; why not the U.S.? We must not tiptoe around the truth: Our global leadership and competitiveness in the research arena is slipping away from us; young scientists crucial to future medical progress are leaving the profession (or moving to China); Americans are dying prematurely or living with chronic pain, severe mobility limitations and other profoundly challenging disabilities; and health care costs remain a difficult issue. Investing in an environment that empowers public and private sector funded research is the appropriate countermeasure to these grim realities; why is it being ignored? The most eye-opening report on the impending loss of U.S. global leadership that I have read of late is Michael Specter’s “Letter from Shenzhen” in the current New Yorker; it follows on my “Sputnik moment” LTE in The New York Times almost eerily, although this time it’s not about space science but the genome.
Our work plan for 2014 — the year Research!America marks as our 25th anniversary — is to work in close collaboration with our members and our colleagues in the advocacy community to build and execute strategies around these resolutions. Together, we will work to achieve higher funding for our federal health agencies; smart policies that empower, rather than impede, private sector innovators; and, most importantly, unleash the palpable potential for making unprecedented medical progress. Please join me in kicking off the new year by reaching out to policy makers, especially appropriators working against a tight deadline, with messages of resolve for 2014.
A Weekly Advocacy Message from Mary Woolley: Call in Friday morning to help change the national conversation
Dear Research Advocate:
Research!America, in partnership with the American Society of Hematology, released a new poll on Tuesday, revealing strong feelings about the consequences of recent fiscal debacles. A majority (57%) of Americans, across party lines, believe that the government shutdown in October caused significant harm to programs like medical research, defense and education, programs that Americans value. It is not difficult to connect the dots between fiscal dysfunction and the future of our nation: More Americans than ever believe that our nation’s global leadership in science, technology and research will soon be a thing of the past,with 73% saying we will lose global leadership by 2020 — just six years from now. A plurality says China will surpass us by then. This perception is not far off base. China and other countries, including most recently Mexico, are making major commitments to their research and innovation infrastructure. They are determined to drive their economy and contribute to health and prosperity by following what was for years the leadership example set by the U.S.
Last month, following President Enrique Peña Nieto’s leadership, the Mexican Congress increased the budget for the primary national science and technology agency by 20% for 2014 and increased the nation’s overall science budget by 12%. Battelle predicts that China’s dramatic increases in federal research spending have positioned the nation to overtake the U.S. in total R&D investment within a few short years. It’s high time we match the bold visions of Mexico, China and many other nations. Continue reading →
Op-ed by Abigail Schindler, PhD, postdoctoral fellow at the University of Washington, Department of Psychiatry and Behavioral Sciences and co-leader of the Seattle Forum on Science Ethics and Policy published in The Seattle Times.
When I think about not being a scientist anymore my heart hurts. But sadly, due to continued budget cuts to biomedical research, within the next few years that is most likely exactly what I will be — no longer a scientist, no longer a researcher searching for cures for disease.
And I am not alone. The number of young scientists being forced out of basic biomedical research in the United States is increasing at an alarming rate, and when this next generation of scientists leaves, it is not coming back.
Like me, these are early career scientists trained in the United States by U.S. tax dollars. We are scientists whose life goal has been to one day have our own research program at an academic institution committed to the search for breakthroughs and cures. Yet because of these budget cuts, catchphrases such as the “brain drain” are proving true. This is a bad omen for U.S. global leadership in biomedical research and the future health and wellness of our nation.
The National Institutes of Health (NIH) is the nation’s premier biomedical research agency and the leading supporter of biomedical research in the world. Despite numerous public polls showing strong support among Americans for government funding of basic biomedical research, NIH’s budget was cut by $1.5 billion this year, or 5 percent, from $31 billion. Continue reading →
Research!America President and CEO Mary Woolley’s Statement on Senate Labor-HHS-Education Appropriations Subcommittee Markup of FY14 Bill
July 9, 2013
The Senate subcommittee markup of the Labor-Health and Human Services-Education FY14 spending bill goes a step in the right direction in softening the blow sequestration has dealt to the hopes and expectations of patients and their families. Sequestration’s across-the-board spending cuts have sent no-confidence signals across the full ecosystem of medical research and innovation in the public and private sector. There’s a reason that, according to a recent national public opinion poll commissioned by Research!America, nearly half of Americans (48%) do not believe we are making enough progress in medical research in the U.S. This nation can’t push ahead forcefully with one hand tied behind its back. Our global leadership in research and development is at risk as other countries accelerate investments in research and development and roll out the welcome mat for young scientists unable to secure grants in the U.S. as a result of spending cuts. We commend Senators Tom Harkin and Jerry Moran and members of the subcommittee for their efforts to restore the National Institutes of Health (NIH) budget, and urge the full committee to do still more. There’s no downside to doing all we can to support research that will help us improve health, drive our economy and contribute to the nation’s security. That’s the track record of the NIH; this is not the time to shortchange it.